ArticleInternational journal of impotence research2026
Perception and Reality of Postoperative Penile Length in Men Undergoing Plaque Excision and Grafting for Peyronie's Disease.
Article in International journal of impotence research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Partial plaque excision and grafting (PEG) is the gold standard treatment for patients with severe Peyronie's Disease (PD) with preserved erectile function and deformity refractory to conservative management. Post-PEG satisfaction rates are highly variable, with many patients attributing dissatisfaction to penile shortening. We aim to explore patient-reported penile shortening in the pre- and postoperative period. A retrospective chart review and telephone survey was conducted for 137 patients who underwent PEG at a single institution from February 2007 - November 2022. Overall, 75.2% of patients had measured increased or stable stretched penile length (SPL) following PEG, with a mean gain of 1.5 ± 0.9 cm in those who objectively gained length. 75.9% of patients reported preoperative perceived shortening; 46.0% reported postoperative perceived shortening. Perceived preoperative shortening was associated with perceived postoperative shortening (84.1% vs 68.9%, p = 0.03). There was no significant association between perceived postoperative shortening and objective change in SPL (p = 0.38). Subjective postoperative shortening was associated with lower satisfaction rates (38.1% vs 58.1%, p = 0.002) and shorter median follow-up (21 vs 53 months, p = 0.007). Although PEG generally results in SPL gain, managing expectations is critical, with emphasis that the goal of PEG is to achieve functional straightness and rigidity, not necessarily restore penile length lost to PD.
Identifiers
42675234What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.